Abstract:ABSTRACT Mechanistic investigations are of paramount importance in elucidating the modes of action of antibiotics and facilitating the discovery of novel drugs. We reported a luciferase-based reporter system using bacterial cells to unveil mechanisms of antimicrobials targeting transcription and translation. The reporter gene Nluc encoding NanoLuciferase (NanoLuc) was integrated into the genome of the Gram-positive model organism, Bacillus subtilis , to generate a reporter strain BS2019. Cellular transcription and translation levels were assessed by quantifying the amount of Nluc mRNA as well as the luminescence catalyzed by the enzyme NanoLuc. We validated this system using three known inhibitors of transcription (rifampicin), translation (chloramphenicol), and cell wall synthesis (ampicillin). The B. subtilis reporter strain BS2019 successfully revealed a decline in Nluc expression by rifampicin and NanoLuc enzyme activity by chloramphenicol, while ampicillin produced no observable effect. The assay was employed to characterize a previously discovered bacterial transcription inhibitor, CUHK242, with known antimicrobial activity against drug-resistant Staphylococcus aureus . Production of Nluc mRNA in our reporter BS2019 was suppressed in the presence of CUHK242, demonstrating the usefulness of the construct, which provides a simple way to study the mechanism of potential antibiotic candidates at early stages of drug discovery. The reporter system can also be modified by adopting different promoters and reporter genes to extend its scope of contribution to other fields of work. IMPORTANCE Discovering new classes of antibiotics is desperately needed to combat the emergence of multidrug-resistant pathogens. To facilitate the drug discovery process, a simple cell-based assay for mechanistic studies is essential to characterize antimicrobial candidates. In this work, we developed a luciferase-based reporter system to quantify the transcriptional and translational effects of potential compounds and validated our system using two currently marketed drugs. Reporter strains generated in this study provide readily available means for identifying bacterial transcription inhibitors as prospective novel antibacterials. We also provided a series of plasmids for characterizing promoters under various conditions such as stress.

A Covalent Reporter of b -

Detection of mcr-1-harbouring<i> Escherichia</i><i> coli</i> by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors

Atypical pleomorphic xanthoastrocytoma.

β-Lactamase Sensitive Probe for Rapid Detection of Antibiotic-Resistant Bacteria with Gas Chromatography-Tandem Mass Spectrometry

A simple design of fluorescent probes for indirect detection of β-lactamase based on AIE and ESIPT processes

Antibiotics-based Fluorescent Probes for Selective Labeling of Gram-negative and Gram-positive Bacteria in Living Microbiotas

Metabolic labeling-mediated visualization, capture, and inactivation of Gram-positive bacteria via biotin–streptavidin interactions

Fluorescently Modified NDM-1: A Versatile Drug Sensor for Rapid In Vitro β-Lactam Antibiotic and Inhibitor Screening

Superresolution imaging of antibiotic-induced structural disruption of bacteria enabled by photochromic glycomicelles

A long fluorescence lifetime probe for labeling of Gram-negative bacteria

Fluorogenic Probes of the Mycobacterial Membrane as Reporters of Antibiotic Action

A visualization reporter system for characterizing antibiotic biosynthetic gene clusters expression with high-sensitivity

A Versatile Two-Photon Fluorescent Probe for Ratiometric Imaging E. Coliβ-Galactosidase in Live Cells and in Vivo.

A Galactosidase-Activatable Fluorescent Probe for Detection of Bacteria Based on BODIPY

Dna Diagnostics with A Bacterial Reporter Probe

Chemically programmable bacterial probes for the recognition of cell surface proteins

Point-of-Care Detection of Β-Lactamase in Milk with a Universal Fluorogenic Probe

In vivo Labeling and Intravital Imaging of Bacterial Infection using a Near‐infrared Fluorescent D‐Amino Acid Probe

A deep-red fluorogenic antimicrobial peptide for rapid wash-free staining and detection of bacteria

Development of a luciferase-based Gram-positive bacterial reporter system for the characterization of antimicrobial agents

Rapid and specific labeling of single live Mycobacterium tuberculosis with a dual-targeting fluorogenic probe